Journal of Cardiac Failure
Volume 16, Issue 2 , Pages 128-134, February 2010

Baseline Plasma NT-proBNP and Clinical Characteristics: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial

  • Robert S. Mckelvie, MD, PhD

      Affiliations

    • McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada
    • Corresponding Author InformationReprint requests: Dr. Robert S. McKelvie, Hamilton Health Sciences Corporation – General Site, 237 Barton Street East, Hamilton, Ontario, Canada, L8L 2X2; Tel: (905) 572-7155, Fax: (905) 577-1480.
    • ,
  • Michel Komajda, MD

      Affiliations

    • Pitie-Salpetriere Hospital, Paris, France
    • ,
  • John Mcmurray, MD

      Affiliations

    • University of Glasgow, Glasgow, United Kingdom
    • ,
  • Michael Zile, MD

      Affiliations

    • Medical University of South Carolina and VAMC, Charleston, SC
    • ,
  • Agata Ptaszynska, MD

      Affiliations

    • Pharmaceutical Research Institute, Bristol-Myers Squibb, Princeton, NJ
    • ,
  • Mark Donovan, PhD

      Affiliations

    • Pharmaceutical Research Institute, Bristol-Myers Squibb, Princeton, NJ
    • ,
  • Peter Carson, MD

      Affiliations

    • Georgetown University and VAMC, Washington, DC
    • ,
  • Barry M. Massie, MD

      Affiliations

    • University of California San Francisco and VAMC, San Francisco, CA
    • ,
  • I-Preserve Investigators

Received 28 August 2008; received in revised form 27 July 2009; accepted 24 September 2009. published online 05 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 All decisions regarding this manuscript were made by a guest editor.

 All of the authors have disclosures related to the sponsors of the I-Preserve Trial (Bristol Myers Squibb and Sanofi-Aventis): Consulting fees: R.S.M., M.K., J.M., M.Z., P.C., B.M.M.; Research support: R.S.M., M.Z., B.M.M.; Speaking honoraria: R.S.M., M.K., J.M., M.Z., P.C., B.M.M.; Employee of Bristol Myers Squibb: A.P., M.D.

PII: S1071-9164(09)01091-4

doi:10.1016/j.cardfail.2009.09.007

Journal of Cardiac Failure
Volume 16, Issue 2 , Pages 128-134, February 2010

Article Tools